Papa Medical, Inc.

General Information
Business:

(Incorporated in the Cayman Islands)

We are a pioneering provider of end-to-end innovative hemp dosing solutions in the U.S. We sell nebulizers. We engage in key activities in the hemp cannabinoid e-vapors industry, including research and development, formulation design, e-liquid production, e-liquid filling and e-liquid co-packing services. We believe our full-cycle operations and leading market position will position us to further capitalize on the growth potential of the U.S. hemp cannabinoid e-vapors market.

Our leading atomization technology, AiMesh® technology, significantly facilitates precise metering control, and our high-end aroma molecule blending technology, feelmixX® technology, perfectly combines traditional CBD oil with modern e-vapor oil, positioning us to provide broader applications across different sectors. Our hemp cannabinoid e-vapors are marketed under the Cannapresso brand name, primarily on an Original Design Manufacturer (“ODM”) basis to other hemp vapor companies. ODM generally involves the design and customization of the core products to meet a brand’s unique image and needs. Our products are sold by our customers under their own brand names although they may also include our brand name on the products.

Note: Net income and revenue are for the 12 months that ended March 31, 2025.

Industry: Cannabinoid - Hemp - Pain relief & anxiety relief
Employees: 47
Founded: 2018
Contact Information
Address 202 North California Ave City of Industry, CA 91744
Phone Number (626) 855-0800
Web Address https://www.papamedical.com/
View Prospectus: Papa Medical, Inc.
Financial Information
Market Cap $85.0mil
Revenues $46.97 mil (last 12 months)
Net Income $1.34 mil (last 12 months)
IPO Profile
Symbol PAPA
Exchange NASDAQ
Shares (millions): 1.3
Price range $4.00 - $4.00
Est. $ Volume $5.0 mil
Manager / Joint Managers US Tiger Securities/TFI Securities
CO-Managers
Expected To Trade: 9/2/2025
Day: Week of
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change